ADVERTISEMENT
ADVERTISEMENT
Drugging the Undruggable
Drugging the Undruggable
Learn how cutting-edge strategies empower researchers to target undruggable proteins.
Drugging the Undruggable
Drugging the Undruggable

Learn how cutting-edge strategies empower researchers to target undruggable proteins.

Learn how cutting-edge strategies empower researchers to target undruggable proteins.

antibodies

Image of the monocled cobra, a venomous cobra species.
pH-Engineered Venom-Fighting Antibodies
Laura Tran, PhD | Oct 11, 2024 | 4 min read
A combinatorial approach enabled researchers to develop antibodies with improved catch-and-release abilities against snake venom toxins.
iStock
Harnessing Molecular Farming’s Potential
Priyom Bose, PhD | Sep 5, 2024 | 8 min read
Molecular farming is a promising technique that enables the production of biopharmaceuticals and other high value compounds in plants.
An illustration of a B cell secreting autoantibodies.
Autoimmune Diseases: An Alternative Application for Immunotherapy
The Scientist | Aug 23, 2024 | 1 min read
Learn how immunotherapy is revolutionizing autoimmune disorder treatment.
Snake slithering across dirt. 
Snaking Towards Synthetic Antivenoms
Danielle Gerhard, PhD | May 31, 2024 | 6 min read
After more than a century of producing animal-based antivenoms, scientists turned to synthetic systems to develop safer and more effective snake bite treatments.
An illustration of a<em >&nbsp;</em>macrophage internalizing <em>Staphylococcus aureus</em> through phagocytosis and presenting antigens to a T cell with many bacterial cells surrounding the immune cells.
Tackling a Pathogen That Leaves a Lasting Impression
Charlene Lancaster, PhD | May 6, 2024 | 5 min read
Staphylococcus aureus vaccine efficacy depends on the immune imprints from past exposures to the microbe.
Optimers Bring Precision to Cancer Research and Therapeutics
Optimers Bring Precision to Cancer Research and Therapeutics
The Scientist Staff | Apr 24, 2024 | 1 min read
In this webinar, David Bunka will discuss how scientists can use Optimer® binders in cancer research. 
An illustration of purple-colored single domain antibodies floating in front of a black background.
Single Domain Antibodies: Small but Mighty Therapeutics
The Scientist | Mar 22, 2024 | 1 min read
Discover the benefits of VHH antibody-based therapies.
Building Broader B Cell Diversity for Better Monoclonal Antibody Discovery<br ><br>
Building Broader B Cell Diversity for Better Monoclonal Antibody Discovery
The Scientist Staff | Feb 5, 2024 | 1 min read
In this webinar, Vincent Pai will discuss how the latest automated single B cell functional screening technology helps researchers meet the demands for new monoclonal antibody candidates.
The mouse peripheral nervous system with nerve cells farther away from the camera represented in yellow and pink, while nerves closer to the camera are shown in blue tones.
A Glowing Mouse Map
Mariella Bodemeier Loayza Careaga, PhD | Feb 1, 2024 | 2 min read
A whole-body immunostaining method allowed researchers to achieve cellular resolution at the whole-organism level.
A futuristic-style 3D rendered hand holding a synthetic DNA structure.
Synthetic Libraries: Where Science Meets Impact
Twist Bioscience | Oct 24, 2023 | 1 min read
Find answers to common synthetic biology research questions in this collection of quick educational videos.
Kaitlyn Sadtler standing in front of a laboratory bench
Spectral Flow Cytometry: Separating the Fluorophore Rainbow
Charlene Lancaster, PhD | Oct 24, 2023 | 3 min read
Spectral flow cytometry separates similarly emitting fluorophores and enabled Kaitlyn Sadtler to construct a 24-color rat panel for immunological analyses.
Futuristic wavy mounds in purple, pink, and red
Adding Another Dimension to Traditional Immunoassays
Bio-Techne | Oct 16, 2023 | 1 min read
With an automated capillary electrophoresis platform, researchers simplify protein analysis while obtaining more information from each sample.
New Strategies for Cancer Immunotherapy
New Strategies for Cancer Immunotherapy
The Scientist | Sep 13, 2023 | 2 min read
An expert panel will discuss the interplay between cancer and the immune system, and how researchers develop immunotherapies and other immune-supporting strategies against cancer. 
An illustration of antibodies floating in solution.
Biotherapeutic Antibodies: Journey from the Benchtop to the Clinic
Cytiva | Aug 29, 2023 | 1 min read
Translational scientists employ surface plasmon resonance (SPR) to make informed decisions when choosing their lead antibody candidates. 
Cancer Vaccines: A Dose of Prevention
Cancer Vaccines: A Dose of Prevention
The Scientist | Aug 10, 2023 | 1 min read
Discover the latest progress behind therapeutic vaccines that boost the immune system’s cancer-killing abilities.
T cell antigen binding site
Multiple Targets, Infinite Possibilities
The Scientist Staff | Aug 1, 2023 | 2 min read
Multispecific antibodies are rising stars in the field of antibody therapeutics, offering better specificity, targeting ability, and therapeutic effects than traditional monoclonal antibodies.
Learn about the latest research on optimal vaccine-induced immune responses
Modulating the Immune Response to Vaccines
The Scientist | Apr 26, 2023 | 1 min read
Researchers uncover innovative natural approaches to fine-tune immunity from vaccination.
Efficient and Flexible Spatial Multiplexing: Assay Development Guidelines for ChipCytometryTM
Efficient and Flexible Spatial Multiplexing: Assay Development Guidelines for ChipCytometryTM
The Scientist | Feb 10, 2023 | 1 min read
In this webinar, Karen Kwarta will discuss advancements in cellular multiplexing assay technology.
Training the Immune System to Fight Chronic Diseases
Training the Immune System to Fight Chronic Diseases
The Scientist | Dec 21, 2022 | 1 min read
Learn how researchers analyze and engineer antibodies to better understand antibody function and development for disease therapeutics.
ADVERTISEMENT